Navigation Links
Don't Prescribe Antibiotics for Adult Sinus Woes
Date:3/13/2008

at patients demand, Leopold said. "Many patients call up and ask for specific antibiotics," he said. "The patients know these names. They have been marketed to them, so they know the drugs are available. And antibiotics do give some relief."

According to the Archives of Otolaryngology Head and Neck Surgery report, two national studies showed that Americans made more than 17 million visits to health-care facilities for sinus infections between 1999 and 2002. At least one antibiotic was prescribed in nearly 83 percent of cases of acute rhinosinusitis and in nearly 70 percent of cases of the chronic, longer-running version of the condition, in which symptoms persist for at least 12 weeks.

Doctors understand that overprescribing antibiotics can lead to a dangerous microbial resistance to the drugs. But it's hard to preach that wisdom to someone with a drippy, hurting sinus who wants immediate relief, Leopold acknowledged. Because more effective drugs are lacking, "patients are desperate, physicians are desperate, and it is not a happy situation," he said.

Consider the case of the working physician called on to treat such a patient, said Dr. Neil L. Kao, vice chairman of the rhinitis/sinusitis committee of the American College of Allergy, Asthma and Immunology. He happens to be just such a working physician, in private practice in Greenville, S.C.

There are ways to determine whether a sinus infection is bacterial, Kao said. One is to do endoscopy, running a tube into the nose to obtain a sample of mucus from the sinus. Another is nasal cytology, examining a swab from the lining of the nose. A third is to take an X-ray.

"The problem with all of these is that they are expensive and time-consuming," Kao said. "The differences between symptoms caused by an allergy, bacterial infection, viral infection and a common cold are few. For us, even specialist doctors, when you see someone with acute nasal symptoms, it
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Most With High Blood Pressure Dont Follow Recommended Diet
2. Survey confirms Americans prefer root canal treatment by endodontists
3. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
4. Treating your periodontal pockets may benefit your pocket book
5. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
6. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
7. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
8. Bone-Strengthening Drugs May Be Overprescribed
9. Almost Half of Doctors Have Prescribed Placebos
10. Internists Diagnose Health Care System Ills, Prescribe Remedies to Achieve Universal Coverage, Better Quality, and Lower Costs
11. TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Don't Prescribe Antibiotics for Adult Sinus Woes
Don't Prescribe Antibiotics for Adult Sinus Woes
(Date:7/24/2008)... CosmetaLife clinical trial results could lea... ,cost-effective treatment for deep lines and wrin... Minn. (PRWEB) July 24, 2008 -- Gel-Del Technolog...e company announced that it has concluded clinical...that company officials say holds potential to be a...
(Date:7/24/2008)... The Palomino Group, a leading commercializat... announced the launch of its new Meeting Support S...tical industry. The company, based in Minneapolis,...ialization consulting services that support biotec... healthcare companies. , ...
(Date:7/24/2008).../PRNewswire-FirstCall/ --, Key Highlights, Misys...ions and is now,raising targets for the next phase...(1) of GBP492m up 6%, bringing Group operating pro... executing on its strategy and entering,into the n...orm for growth., To view the Multimedia News Rele...
(Date:7/23/2008)...ular Entities Drops to Historic Low as Pharma Comp...nerics Companies, LONDON, July 24 /PRNewswire/ --...announced the availability of the newly published ..., an indispensable reference,and business planning...orporate finance, business strategy, marketing pla...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2
...g blind and partially sighted people in the Lothia...e for the Blind (RNIB) received a ?25,000 donation...help in launching the charity's Positive Steps pro...ning for people preparing to enter employment. Th...
... for Type 2 Diabetes appears to have a twin benefi...ar under control// but also helps them to lose wei...n associate Professor with the Royal Prince Alfred...this drug has been under trial on patient voluntee...
... of teeth, do not improve the mental well being an...study//. Thousands of children have orthodontic wo...n the dental profession that braces or orthodontic...ll-being, reported the online edition of BBC News....
...cer deaths for the second consecutive year, the Am...can Health Challenge// to educate and motivate Ame... Many Americans are concerned about potentially d...t 50 percent of cancer deaths could be prevented t...
Other Medicine News:Health News:Healthy Behaviors Can Prevent at Least 50 Percent of Cancer Deaths 2
(Date:7/22/2008)...(R) Resulted in Significant, Reductions in A1C in ...thm Used, BRIDGE...the "Adjust to,Target in Type 2 Diabetes: Comparis...for Adjustment of Mealtime Insulin Glulisine" stud...tion,s (ADA) medical journal,Diabetes Care. This ...
(Date:7/22/2008)...wswire/ -- Hyperion,Therapeutics, Inc. today annou...ts Phase 1/2 clinical trial to evaluate the safety...PN-100 (formally called GT4P) versus,BUPHENYL(R) (... disorders,(UCD). The company plans to announce to..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
(Date:7/22/2008)...rsity Medical Center Based on Rosetta Ge...t Differentiates Squamous From Non-Squamous Non-Sm...s-Cell Carcinoma of the Lung With Sensitivi...s is the First CLIA Approved Test Which Leverages ...Accurate Diagnosis of Lung Cancer, REHOVOT, Israe...
(Date:7/22/2008)...ire-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX)...,enrollment of 417 osteoarthritis (OA) patients wi...ology studies in the United States, in line with,p...signed to assess the,blood pressure profile of nap... using the Ambulatory Blood Pressure Monitoring (A...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events 21808 1Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events 21808 2Nanoparticles aid bone growth 21804 1Nanoparticles aid bone growth 21804 2Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3 21800 1Courage Center Extends Nomination Deadline for 2008 Phillips Awards to July 3 21800 2Threatened or invasive 3F Species fates identified 3631 1Threatened or invasive 3F Species fates identified 3631 2
...Northfield,Laboratories Inc. (Nasdaq: NFLD) announ...has informed the Company that the report of,the su... with,PolyHeme(R), the Company,s human-hemoglobin ...t be complete until May., About Northfield Laborat...n developing an,oxygen-carrying red blood cell sub...
...tic,benefits of adding Diovan to conventional ther...mes for,Diovan patients , , , BASEL,Switzerlan...dent,Jikei Heart Study, published today in The Lan...ng medication Diovan® to,conventional therapy ...r events and a 40% reduction in stroke. , , The ...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
The GENESIS II* Total Knee System will define the state of knee implants.
Cruciate Retaining, Posterior Stabilized and Constrained Components.
StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Medicine Products: